As our partner you get access to leading global technology in development, as well as large-scale production capacity.
Novartis provides you with the flexibility you need to successfully develop and produce innovative recombinant products that transform patients’ lives.
The competence center of microbial cGMP and cell-bank manufacturing of Novartis is located in Austria. Upstream and downstream capabilities are available on a scale from 150 to 40,000 liters for clinical and commercial scale manufacturing of your microbial-based products.
We offer customized solutions with our ability to handle increasing demand levels quickly and efficiently without the need for costly and time-intensive transfers.
Customized solutions and efficient handling for your microbial-based products.
Flexible microbial manufacturing scaling
With upstream and downstream capabilities ranging from 150 to 40,000 liters, we can provide you with both clinical and commercial manufacturing.
Services and technologies
Mammalian cell culture
State-of-the-art mammalian cell culture manufacturing at clinical and commercial scale.
Microbial manufacturing
Customized solutions and efficient handling for your microbial-based products.
Cell & Gene
Rely on a leading Cell & Gene therapy manufacturer with an excellent team and high-tech facilities for clinical and commercial scale.
Plasmid DNA & RNA
High-quality plasmid DNA and RNA manufacturing for various types of RNA drugs (including siRNA), mRNA vaccines and innovative gene and cell therapies.
Fill & Finish
A fully integrated set of services and solutions for aseptic fill and finish of medicinal products.
Viral vectors
Producing viral vectors for vaccines or cell and gene therapy in a state-of-the-art facility.
